SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-011067
Filing Date
2019-11-14
Accepted
2019-11-14 16:36:00
Documents
68
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20190930x10q.htm 10-Q 1595131
2 EX-3.1 rsls-20190930ex31b309155.htm EX-3.1 18641
3 EX-31.1 rsls-20190930ex311cce3d2.htm EX-31.1 13517
4 EX-31.2 rsls-20190930ex3129afcbb.htm EX-31.2 14921
5 EX-32.1 rsls-20190930ex321a95ce3.htm EX-32.1 11830
6 EX-32.2 rsls-20190930ex32200d704.htm EX-32.2 12091
  Complete submission text file 0001558370-19-011067.txt   5692398

Data Files

Seq Description Document Type Size
7 EX-101.INS rsls-20190930.xml EX-101.INS 907933
8 EX-101.SCH rsls-20190930.xsd EX-101.SCH 45519
9 EX-101.CAL rsls-20190930_cal.xml EX-101.CAL 65013
10 EX-101.DEF rsls-20190930_def.xml EX-101.DEF 198295
11 EX-101.LAB rsls-20190930_lab.xml EX-101.LAB 393842
12 EX-101.PRE rsls-20190930_pre.xml EX-101.PRE 353282
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33818 | Film No.: 191221010
SIC: 3845 Electromedical & Electrotherapeutic Apparatus